10:45 – 11:15: Update on mechanism of lipopeptide action
Speaker: Tanja Schneider, PhD, University of Bonn, Germany

11:15 – 11:45: Collateral damage of rifaximin prophylaxis in VRE
Speaker: Glen Carter, PhD, University of Melbourne

11:45 – 12:15: Non-traditional approaches to gram-positive infections
Speaker: Victor Nize MD, University of California San Diego